RecruitingMale onlyEN originalProstate cancer

Nerve-SPARing Robotic Prostatectomy: The Impact of Patient Baseline Profiles on Erectile Function

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

1. STUDY PURPOSE: Robot-assisted surgery for prostate cancer aims to remove the tumor while preserving the delicate nerves that control erections (called "nerve-sparing" surgery). Even with advanced robotics, some patients still experience erectile dysfunction after surgery. Recovery depends not only on the surgeon's technique (one-sided or two-sided nerve sparing), but also on patient unique baseline health profile. The present study aims to analyze how patient age, health history (like diabetes or high blood pressure), and pre-surgery sexual function affect recovery. Doctors will use this data to create a personalized prediction tool (a nomogram) to better advise future patients. 2. STUDY DESIGN: This study will not change, delay, or interfere with participants' standard medical care. The surgeon will choose the safest surgical path to treat cancer. To ensure the highest quality and eliminate surgical bias, all operations will be performed by a single, highly experienced robotic surgeon who has completed over 5,000 procedures. If patients agree to join, participants will be asked to fill out private health questionnaires at four specific time points: Baseline: Before surgery. Follow-ups: At 3 months, 6 months, and 12 months after surgery. 3. STUDY MEASUREMENTS: Erectile Function: Patient ability to achieve a functioning erection (with or without the help of medications like Viagra) at the 12-month mark compared to patient baseline. Oncological Safety: Routine checks of patient PSA levels and surgical margins to guarantee that sparing the nerves did not compromise cancer cure

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Wiek od 18 do 75 lat
  • Potwierdzony histologicznie rak prostaty ograniczony do narządu
  • Kwalifikacja do robocznej operacji usunięcia prostaty z zamiarem ochrony nerwów
  • Gotowość wypełniania ankiet zdrowotnych przed operacją i w okresie obserwacji
  • Podpisana zgoda na udział w badaniu

✗ Disqualifies

  • Ciężkie zaburzenia erekcji niezwiązane z rakiem prostaty
  • Poprzednia radioterapia miednicy, kriochirurgia lub rozległa chirurgia miednicy
  • Leczenie hormonalne przed operacją
  • Poważne problemy psychiatryczne lub poznawcze uniemożliwiające wiarygodne odpowiadanie na pytania

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Maximum age
75 Years
Last updated (source)
August 5, 2026
Sex
Male only

Locations (1)

AOU Careggi

Florence, Italy

Trial contact

Antonio Andrea Grosso AAG MD, PhD

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/6/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.